Wisconsin Alumni Research Foundation

Therapeutics & Vaccines
Therapeutics Vaccines
High Titer Recombinant Influenza Viruses With Enhanced Replication In Mdck Or Vero Cells Or Eggs
WARF: P130287US02

Inventors: Yoshihiro Kawaoka, Gabriele Neumann, Jihui Ping

The Invention
The invention provides a composition useful to prepare high titer influenza viruses, e.g., in the absence of helper virus, which includes internal genes from an influenza virus vaccine strain or isolate, e.g., one that is safe in humans, for instance, one that does not result in significant disease, that confer enhanced growth in cells in culture, such as MDCK cells, or in eggs.
Additional Information
Related Intellectual Property
For current licensing status, please contact Jennifer Gottwald at [javascript protected email address] or 608-960-9854